~~<i id='A4C55934ED'><strike id='A4C55934ED'><tt id='A4C55934ED'><pre id='A4C55934ED'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：hotspot 2025-09-29 00:38:58 - browse：69

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The Pandemic Treaty must support building strong health systems

leisure time

focus

Wikipedia

entertainment

leisure time

AdobeAsBristolMyersSquibbworkstobuilditstreatmentforaheartconditionthatcancausedifficultybreathingin

WSS

Let's speed up science by embracing open access publishing

Patients, digital health players weigh in on FTC's data privacy plan

See how much Covid

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Schizophrenia gene found to be linked to cells' energy dysfunction

Wikipedia

fashion

leisure time

The high cost of giving birth even with insurance

BMI, flaws aside, is found to be useful estimate of body fat in youth

Malaria cases in Florida and Texas: Here’s what you need to know

BMS, looking to build heart drug business, turns to AI for diagnosis

FDA approval of Sarepta Duchenne genetic therapy gives me hope

At ASCO, AstraZeneca reports strong data for breast cancer drug

Jerome Adams on the need for new antivirals for Covid

Change Healthcare can notify patients about the breach, HHS says

How one medical school became remarkably diverse

Ionis drug prevents swelling attacks due to hereditary angioedema

leisure time

Treatments for cramps don't cut it. Why aren't there better options?

Senators push IRS to launch nonprofit hospital probe

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Be careful with at

Treatments for cramps don't cut it. Why aren't there better options?

After Optum profits sink, UnitedHealth makes changes

focus

Wikipedia

entertainment

leisure time